Redox Dual‐Responsive Drug Delivery System with Cascade of Reactive Oxygen Species Self‐Generation for Enhanced Cancer Chemotherapy
Advanced Healthcare Materials · 2026-05 · 15 (18)
DOI: 10.1002/adhm.71002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 04.03.2026. Verfasst von Ling Zeng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Research Center, Department of Pharmacy, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China. Hauptthemen laut MEDLINE: Reactive Oxygen Species, Paclitaxel, Drug Delivery Systems, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Shenzhen Science and Technology Program, Guangdong Basic and Applied Basic Research Foundation, Research Start-up Fund of the Seventh Affiliated Hospital, Sun Yat-sen University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Conventional chemotherapy is significantly hampered by the inherent hydrophobicity of chemotherapeutic agents, limited tumor‐specific targeting, and inadequate intratumoral accumulation, all of which undermine its clinical efficacy. Nonselective distribution of cytotoxic agents leads to suboptimal drug concentrations within tumor tissues, causing systemic toxicity in healthy organs. Tumor microenvironment‐responsive nanoplatforms offer a promising strategy for enhancing specificity and efficacy. This study demonstrates the successful development of a nanodrug delivery system, CASS@PTX nanoparticles, where CASS is a cinnamaldehyde‐based, disulfide‐containing polymer engineered with dual‐stimulus responsiveness to glutathione (GSH) depletion and reactive oxygen species (ROS) amplification. This system disrupts intracellular redox homeostasis in tumor cells, triggering the release of encapsulated paclitaxel (PTX) while enhancing chemotherapeutic efficacy through redox‐dependent sensitization. GSH consumption and ROS overproduction create a prooxidative microenvironment that enhances PTX‐induced apoptosis. Preclinical validation using in vitro cytotoxicity assays and in vivo tumor models demonstrates potent synergistic anti‐tumor effects with minimal systemic toxicity. This cascading ROS self‐generation strategy represents a promising approach for overcoming multidrug resistance and improving the therapeutic outcomes of cancer chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Research Center, Department of Pharmacy, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
- Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
- Department of Anesthesiology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
- Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
ORCID-Profile: Yining Wang, Youpeng Chen, Yang Kang
Förderung
- Shenzhen Science and Technology Program
- Guangdong Basic and Applied Basic Research Foundation
- Research Start-up Fund of the Seventh Affiliated Hospital, Sun Yat-sen University
- Key Research and Development Program of Hunan Province
- National Natural Science Foundation of China
- Funding of Shenzhen Clinical Research Center for Gastroenterology
- Shenzhen Science and Technology Innovation Program
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Zeng, L., Ding, N., Chen, Z., Zheng, X., Liu, X., Zhang, H., Lv, X., Wang, Y., Chen, Y., Hu, M., & Kang, Y. (2026). Redox Dual‐Responsive Drug Delivery System with Cascade of Reactive Oxygen Species Self‐Generation for Enhanced Cancer Chemotherapy. Advanced Healthcare Materials, 15(18). https://doi.org/10.1002/adhm.71002
Vancouver
Zeng L, Ding N, Chen Z, Zheng X, Liu X, Zhang H, et al. Redox Dual‐Responsive Drug Delivery System with Cascade of Reactive Oxygen Species Self‐Generation for Enhanced Cancer Chemotherapy. Advanced Healthcare Materials. 2026;15(18). doi:10.1002/adhm.71002
BibTeX
@article{Zeng2026,
author = {Zeng, Ling and Ding, Ni and Chen, Zhiyang and Zheng, Xiaoming and Liu, Xin and Zhang, Hao and Lv, Xing and Wang, Yining and Chen, Youpeng and Hu, Min and Kang, Yang},
title = {Redox Dual‐Responsive Drug Delivery System with Cascade of Reactive Oxygen Species Self‐Generation for Enhanced Cancer Chemotherapy},
journal = {Advanced Healthcare Materials},
year = {2026},
volume = {15},
number = {18},
doi = {10.1002/adhm.71002}
}
EUVIMED